Bantie L, Tadesse S, Likisa J, Yu M, et al. A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer. Gynecol Oncol 2020 Sep 18. pii: S0090-8258(20)33905.
PMID: 32958271